Piper Sandler Downgrades Zimmer Biomet Holdings to Neutral, Lowers Price Target to $115
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler has downgraded Zimmer Biomet Holdings (NYSE:ZBH) from Overweight to Neutral and lowered the price target from $140 to $115.
July 01, 2024 | 9:49 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Piper Sandler has downgraded Zimmer Biomet Holdings from Overweight to Neutral and reduced the price target from $140 to $115.
The downgrade from Overweight to Neutral and the significant reduction in the price target from $140 to $115 by Piper Sandler is likely to negatively impact investor sentiment and could lead to a short-term decline in ZBH's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100